financetom
Business
financetom
/
Business
/
Li-Cycle Holdings Plans $75 Million Stock Offering -- Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Li-Cycle Holdings Plans $75 Million Stock Offering -- Shares Fall
Jul 1, 2024 10:58 AM

01:38 PM EDT, 07/01/2024 (MT Newswires) -- Li-Cycle Holdings' ( LICY ) shares fell 16% in recent trading Monday after the company said last week it entered into a deal to sell up to $75 million of common shares via an at-the-market equity offering program.

B. Riley Securities will act as Li-Cycle's ( LICY ) sales agent, or principal, for any offering from time to time under the program.

Li-Cycle Holdings ( LICY ) said it will decide the parameters for the sale, including any price, time or size limits, or other customary conditions.

Net proceeds will be used for general corporate purposes.

Price: 5.48, Change: -1.05, Percent Change: -16.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: FAA Extends Cuts to Minimum Flight Requirements in New York Amid Traffic Controller Shortage
Update: FAA Extends Cuts to Minimum Flight Requirements in New York Amid Traffic Controller Shortage
Jun 6, 2024
08:12 AM EDT, 06/06/2024 (MT Newswires) -- (Updates with details from FAA's statement.) The Federal Aviation Administration said Wednesday it is further extending a waiver of minimum flight requirements at congested New York City-area airports through October 2025. The number of air traffic controllers is insufficient in New York for normal traffic levels, and increasing flexibility is needed to avoid...
Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
Jun 6, 2024
08:14 AM EDT, 06/06/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Thursday that data from the investigational combination of bulevirtide 10 milligram with pegylated interferon alfa-2a, or PegIFN, was superior to investigational bulevirtide 10 mg monotherapy for the treatment of compensated chronic hepatitis delta virus infection. The company is evaluating the efficacy and safety of bulevirtide as monotherapy...
Moderna Says US FDA Selects Rare Genetic Disorder Therapy for Pilot Program
Moderna Says US FDA Selects Rare Genetic Disorder Therapy for Pilot Program
Jun 6, 2024
08:13 AM EDT, 06/06/2024 (MT Newswires) -- Moderna ( MRNA ) said Thursday that the US Food and Drug Administration has selected its experimental therapy, mRNA-3705, to treat methylmalonic acidemia, a rare genetic disorder, for a pilot program aimed at supporting clinical trials to advance rare disease therapeutics. Selection for this program will enable enhanced communication with the US FDA,...
Bloom Energy Partners With Sembcorp Industries for Low-Carbon Electricity in Singapore
Bloom Energy Partners With Sembcorp Industries for Low-Carbon Electricity in Singapore
Jun 6, 2024
08:11 AM EDT, 06/06/2024 (MT Newswires) -- Bloom Energy ( BE ) said Thursday it is partnering with Sembcorp Industries to implement solid oxide fuel cell and carbon capture technologies for low-carbon electricity in Singapore. The clean energy company said the partnership is expected to support Singapore's Green Data Centre roadmap, aiming to create sustainable data centers with green energy....
Copyright 2023-2026 - www.financetom.com All Rights Reserved